Couture R, Gaudreau P, St-Pierre S, Regoli D
Can J Physiol Pharmacol. 1980 Oct;58(10):1234-44. doi: 10.1139/y80-187.
In order to develop a sensitive pharmacological preparation which would allow the measurement of the inhibitory effects of kinins and substance P (SP) in vascular smooth muscles, several large arteries of the dog were studied in vitro. The common carotid artery was found to be one of the most sensitive preparations to SP and kinins. When contracted with low concentrations of noradrenaline (between 3.0 x 10(-8) and 3.0 x 10(-7) M), this artery responds to SP (6.5 x 10(-11)-6.5 x 10(-9) M) and bradykinin (BK) (8.1 x 10(-11)-9.1 x 10(-8) M) with relaxations that are proportional to the concentrations of the two peptides. SP and BK appear to exert their relaxant effects through the activation of specific receptors as the exposure of the common carotid artery to concentrations of [Leu8]-angiotensin II, propranolol, methysergide, cimetidine, or atropine sufficient to inhibit the effects of the corresponding agonists do not affect the relaxing effect of SP and BK. [Leu8]-des-Arg9-BK (1.0 x 10(-6) M), indomethacin (2.8 x 10(-5) M), and lioresal (4.7 x 10(-5) M) are also inactive. When the dog common carotid artery is desensitized with high concentrations of SP, BK, eledoisin, and physalaemin a cross-desensitization is observed only between SP and physalaemin. These results support the conclusion that SP and kinins act on different receptors. The order of potency of kinins is the following: BK = [Tyr(Me)8]-BK greater than des-Arg9-BK, suggesting that the receptor for kinins is of the B2 type. The order of potency of peptides related to SP is SP greater than C-terminal 4-11 greater than C-terminal hexapeptide 6-11, similar to that observed in other vascular preparations. The results summarized in this paper indicate that the dog common carotid artery is a preparation sensitive to SP and BK and useful for studying the relaxant effect of these two peptides on vascular smooth muscles.
为了开发一种灵敏的药理学制剂,用于测量激肽和P物质(SP)对血管平滑肌的抑制作用,对犬的几条大动脉进行了体外研究。发现颈总动脉是对SP和激肽最敏感的制剂之一。当用低浓度去甲肾上腺素(3.0×10⁻⁸至3.0×10⁻⁷M)收缩时,该动脉对SP(6.5×10⁻¹¹至6.5×10⁻⁹M)和缓激肽(BK)(8.1×10⁻¹¹至9.1×10⁻⁸M)产生舒张反应,且舒张程度与两种肽的浓度成正比。SP和BK似乎通过激活特定受体发挥舒张作用,因为将颈总动脉暴露于足以抑制相应激动剂作用的[Leu8]-血管紧张素II、普萘洛尔、甲基麦角新碱、西咪替丁或阿托品浓度下,并不影响SP和BK的舒张作用。[Leu8]-去-Arg9-BK(1.0×10⁻⁶M)、吲哚美辛(2.8×10⁻⁵M)和氯苯氨丁酸(4.7×10⁻⁵M)也无活性。当用高浓度的SP、BK、伊索前列素和蛙皮素使犬颈总动脉脱敏时,仅在SP和蛙皮素之间观察到交叉脱敏。这些结果支持SP和激肽作用于不同受体的结论。激肽的效价顺序如下:BK = [Tyr(Me)8]-BK大于去-Arg9-BK,提示激肽受体为B2型。与SP相关的肽的效价顺序为SP大于C末端4 - 11大于C末端六肽6 - 11,与在其他血管制剂中观察到的顺序相似。本文总结的结果表明,犬颈总动脉是一种对SP和BK敏感的制剂,可用于研究这两种肽对血管平滑肌的舒张作用。